Optase

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Optase
Generic name
GLYCERIN
Manufacturer
Scope Health Inc
Product type
HUMAN OTC DRUG
SPL set ID
f452a2c4-c869-7bf5-e053-2995a90ac1a0
SPL ID
5eb208ba-9798-92ee-e063-6394a90a7f19
Version
7
Effective date
2026-10-25
Source export date
2026-11-13
Source partition
6
Source file
https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/a79c47b73cf1c0b9829667844daa083c5114cf268a1839f963bc5617e9060c4f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 16:20:02
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning • For external use only. • If solution changes color or becomes cloudy, do not use. Stop use and ask doctor if • You feel eye pain. • Changes in vision occur. • Redness or irritation of the eye lasts. • Condition worsens or lasts more than 72 hours

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.